Loading organizations...
Key people at Cross-Border Impact Ventures.
Cross-Border Impact Ventures is a women-led impact venture capital firm investing in health technology companies. It identifies and supports innovative solutions for global market needs in women, children, and adolescent health. The firm leverages technology to improve outcomes, driving systemic change and scaling impactful solutions in underserved regions.
Annie Theriault and Megan Dover co-founded the firm in 2019. Their insight arose from persistent global healthcare disparities for women and youth. With backgrounds in impact investing, they established the firm to back enterprises delivering transformative health solutions worldwide, notably partnering with Grand Challenges Canada.
The firm supports health technology companies developing products and services to enhance health equity. Cross-Border Impact Ventures envisions becoming the preferred investment partner, accelerating the deployment of universally accessible health technologies. Its aim is to foster improved well-being and quality care for women and children worldwide.
Key people at Cross-Border Impact Ventures.
Cross-Border Impact Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $7.5M Series A Extension in Raydiant Oximetry, Inc. in June 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 4, 2024 | Raydiant Oximetry, Inc. | $7.5M Series A Extension | Cross Border Impact Ventures | — |
| Oct 1, 2022 | Daye | $12.0M Series A | — | Avaana Capital, Canvas Ventures, Hambro Perks, MassMutual Ventures, Anne Wojcicki, Fiona Pathiraja, Martin Varsavsky, Michelle Tempest |